XML 18 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Condensed Statements Of Cash Flows
$ in Thousands, SFr in Millions
9 Months Ended
Apr. 30, 2023
USD ($)
Apr. 30, 2022
USD ($)
Statement of Cash Flows [Abstract]    
Net income $ 419,725 $ 477,992
Cash flows from operating activities:    
Depreciation and amortization 199,700 189,214
Stock-based compensation expense 19,062 18,933
Deferred income taxes, net 143,748 127,449
Change in estimated fair value of contingent consideration 47,636 21,580
Other non-cash income, net (4,703) (9,368)
Changes in assets and liabilities:    
Trade receivables, net 32,665 77,226
Inventories, net 4,850 (11,883)
Accounts payable and accrued liabilities (2,183) 46,046
Deferred revenue (62,017) (137,355)
Income taxes payable (63,551) (7,799)
Other assets and liabilities, net (8,049) (19,051)
Net cash provided by operating activities 726,883 772,984
Cash flows from investing activities:    
Capital expenditures (261,259) (161,842)
Return of deposit for acquisition of business 114,506 0
Acquisition of businesses, net of cash acquired (38,567) (116,337)
Investments in short-term deposits (86,756) 0
Proceeds from Sale, Maturity and Collection of Investments 37,978 0
Other investing activities, net 12,838 22,614
Net cash used in investing activities (221,260) (255,565)
Cash flows from financing activities:    
Repayments of borrowings under Vail Holdings Credit Agreement (46,875) (46,875)
Repayments of borrowings under Whistler Credit Agreement 0 (23,145)
Repayment of EB-5 Development Notes 0 (51,500)
Employee taxes paid for share award exercises (5,352) (37,431)
Dividends paid (235,654) (148,851)
Repurchases of common stock (400,000) (37,503)
Other financing activities, net (15,295) (7,348)
Net cash used in financing activities (703,176) (352,653)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (9,921) (1,377)
Net (decrease) increase in cash, cash equivalents and restricted cash (207,474) 163,389
Cash, Cash Equivalents and Restricted Cash:    
Beginning of period 1,126,107 1,258,574
End of period 918,633 1,421,963
Accrued capital expenditures $ 20,099 $ 13,090